A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
about
Stable long-term cultures of self-renewing B cells and their applicationsStructure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial VirusVaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A VirusesInfluenzaReverse vaccinology 2.0: Human immunology instructs vaccine antigen designHepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous ClearanceWhat Are the Most Powerful Immunogen Design Vaccine Strategies?Universal influenza virus vaccines and therapeutic antibodies.Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.Novel universal influenza virus vaccine approachesStalking influenza by vaccination with pre-fusion headless HA mini-stemInfluenza immunology evaluation and correlates of protection: a focus on vaccines.Universal influenza vaccines: Shifting to better vaccines.Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to InfluenzaGeneration and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1.Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched VaccinesProtective immunity against influenza in HLA-A2 transgenic mice by modified vaccinia virus Ankara vectored vaccines containing internal influenza proteins.Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus.Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition.Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza StrainsImplications of broadly neutralizing antibodies in the development of a universal influenza vaccine.Exceptional Antibodies Produced by Successive Immunizations.Influenza-Specific Antibody-Dependent Phagocytosis.Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicityUniversal Influenza Vaccines: To Dream the Possible Dream?Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans.Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine DesignA broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve.
P2860
Q26766723-F782512B-2F06-42E9-A2EF-5F5F356253BAQ27333522-4744A51D-91F5-45EE-A2D4-12C20EA82120Q27644544-E9C8452B-3626-4EE3-B2DD-69DB0AEA8DA6Q28066188-1B194044-17D7-4A8A-B487-3CA2A4374FCCQ28075274-4DBE8EC5-1632-4C39-8EE3-32578864097EQ28552909-F5632918-6618-44B4-8BB1-5BA7C6529CD5Q28729792-C7DF0604-E783-4BFB-802B-DF1BC05CFA08Q30151337-BD35A6E3-3A97-4AE7-93B6-A9CB31993D36Q30384878-CD8F5E0C-C6C5-4EB0-A21B-8287EAFD9142Q30385071-D0E54A45-E7FD-47A7-A309-449007D15FD1Q30385331-567F17D8-E732-4C3C-B3F3-BF6681FA64C4Q30385397-79DE395C-3A1D-4656-AA60-82FE1A38673FQ30386388-AD87A60C-4A15-40BF-867F-04E4669FE403Q30389700-B1A88AC1-B5BB-467E-8B0A-65AB05A79CF6Q30389916-2539E2AB-DA70-4274-BF8F-F6FAAC00A775Q30390233-D90020CB-8286-4335-A4F5-9AB081E39E3AQ30392359-648B130B-55CA-4422-9EB8-FF05A7AAC31FQ30393724-01AAAE4B-A734-4524-9ED2-3CA981404EEDQ30396482-115ABC9A-5A58-47A9-9ABD-0714D70EE64DQ30397362-9888BA3F-1A89-46A0-B245-EA16A23DA6D4Q30397410-1F15874F-0562-4902-B995-889FF29F48F4Q30398002-A5E9A8A0-525B-440F-A391-45C59B019C20Q30398406-C232C8DF-34BC-40AC-9525-255D307AF6F8Q30400230-AC42493B-5BEB-400E-83EC-E7560A663E11Q33724743-EF7E350A-0108-49AE-9ACA-8FB20D540F11Q33821896-EAB253EC-90C1-424D-A458-B7334E6A45D8Q33834779-41439BD6-773D-4C6F-9DC9-D6174F0B1473Q33899438-DD151D2B-ACB9-45C1-9259-DF1BC0235F7DQ34520430-3D95AE30-BD33-4CAF-BD8E-FBEDE3B1DC75Q35862420-BBF7E99E-84D7-4B20-A463-6B076EAEBD77Q36002107-1C55746B-D219-4FAC-9291-13A4D6E9A236Q36050577-13F61D72-E49B-4703-A519-A20DBF1D52D7Q36294782-2099BE99-C915-439E-93FF-040E4EEA18FCQ36434265-B31B1320-B94F-40DE-ACEA-7C07CBAC5E1EQ36583070-E1C4AF87-87C3-4A63-84F5-EE285ADFA570Q36675360-24638BF1-30B9-48A3-9681-8E33FA3D7890Q36970026-BB14C035-303A-456E-B5D3-B7AA0432CD57Q37091569-464395F4-724C-46D7-A423-8FFA6037C8DEQ37252942-9A6AA0B0-8CF1-48F4-9E89-A68E47A4E114Q37263716-C85B1666-E99D-4B21-BAAF-5FFF157B93FE
P2860
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@ast
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@en
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@nl
type
label
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@ast
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@en
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@nl
prefLabel
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@ast
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@en
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
@en
P2093
Adrian Apetri
Andrew B Ward
Anna Zakrzewska
Antonietta Impagliazzo
Başak Kükrer
Danuta Tomkiewicz
Eveline Sneekes-Vriese
Fin Milder
Harmjan Kuipers
Jeroen Huizingh
P2860
P304
P3181
P356
10.1126/SCIENCE.AAC7263
P407
P577
2015-09-18T00:00:00Z